Drug Trial Radar · NCT03537768
Study Comparing Emergency Contraception Effectiveness in Women Who Weight ≥ 80 kg
Last checked: Nov 20, 2026Latest source record: Nov 20, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Terminated
Enrollment
532
Actual
Start
Jul 12, 2018
Primary completion
Apr 20, 2022
Study completion Apr 20, 2022
Sponsor
- Lead sponsor
- Kimberly MyerAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
- First posted
- May 25, 2018
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Single (participant)
- Primary purpose
- Prevention
- FDA-regulated drug
- Yes
- Who can join
- Female only, from 18 years, up to 40 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
The proposed research study is a Phase IIb, multi-center, single-blind, randomized study of UPA 30 mg, LNG 1.5 mg and LNG 3.0 mg to evaluate EC effectiveness in women with weight ≥ 80 kg who present within 72 hours of unprotected intercourse.
Conditions
- Contraception
Interventions
Ulipristal AcetateDrug
UPA Tablet
LevonorgestrelDrug
LNG Tablet
LevonorgestrelDrug
LNG Tablet (x2)
Primary outcomes
What the sponsor says the trial is designed to measure.
- Incidence of pregnancies of UPA 30 mg, LNG 1.5 mg and LNG 3.0 mg in women with weight ≥ 80 kg for emergency contraception (within 72 hours of unprotected intercourse).Time frame: 1-3 months
Locations
18 sites in 1 country. Site status is shown where the registry gives one.
Essential Access Health
Los Angeles, California
University of California, Davis
Sacramento, California
University of California, San Francisco
San Francisco, California
University of Colorado
Denver, Colorado
University of Hawaii
Honolulu, Hawaii
University of Chicago
Chicago, Illinois
Johns Hopkins Bayview Medical Center
Baltimore, Maryland
Planned Parenthood League of Massachusetts
Boston, Massachusetts
Bellevue Hospital Center
New York, New York
Columbia University
New York, New York
University of Cincinnati-Holmes Hospital
Cincinnati, Ohio
University Hospitals of Cleveland MacDonald Women's Hospital
Cleveland, Ohio
Oregon Health Science University
Portland, Oregon
University of Pennsylvania
Philadelphia, Pennsylvania
University of Pittsburgh/Magee Women's Hospital
Pittsburgh, Pennsylvania
Women & Infants Hospital of Rhode Island
Providence, Rhode Island
University of Utah
Salt Lake City, Utah
Eastern Virginia Medical School
Norfolk, Virginia
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.